MemPsych Biotech

Memfocus, with the novel molecule Psychlomin™ (6-MSITC), is generating revenues by addressing the crisis of declining memory, particularly among the aging.

  • Stage Product In Market
  • Industry Biotechnology
  • Location Cincinnati, OH, USA
  • Currency USD
  • Founded January 2024
  • Employees 5
  • Incorporation Type LLC
  • Website Memfocus.com

Company Summary

The 5-member team has nearly 175 years of collective experience in founding biotech and information technology companies.

From the pre-seed round, the Company is generating validating revenues while the burn of the Company is only $8K per month as three of the five members work as needed.

The IP intends to couple Psychlomin™ (6-MSITC), The Memory Molecule™, with an AI-based web app, which adjusts a regimen of Psychlomin and wellness content.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free